Panel Discussion: Effective Preclinical Research and Validating Your Targets

Time: 11:30 am
day: Day 2 Track B - Morning

Details:

  • In the context of Medpharm’s current research into degenerative disease, discuss key ideas involved in the
    phase 1 study design process
  • Consider key target identification principles

Speakers: